Skip to main content
. 2018 Jun 4;2018(6):CD008687. doi: 10.1002/14651858.CD008687.pub2

Comparison 23. Sucralfate versus bioflavonoids.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Clinically important upper GI bleeding 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
2 Number of participants requiring blood transfusion 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected